Please provide your email address to receive an email when new articles are posted on . In an article published in Clinical Endocrinology, Christos Papaioannou, MSc (Hons), a medical student in the ...

Please provide your email address to receive an email when new articles are posted on . Cancer rates for adults with acromegaly are higher than those observed in the U.S. cancer registry. Cumulative ...

A personalized treatment protocol was more effective for management of acromegaly -- also known as gigantism -- than the usual trial-and-error approach, the ...

ACRO/TRUTH Provides Authentic Patient Perspectives, Peer-Reviewed Data on Treatment-Related Symptoms, Side Effects and Quality-of-Life Impact of Current Acromegaly Standard-of-Care SAN DIEGO, Aug. 08, ...

People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, ...

A 23-year-old man was admitted to the hospital with severe dyspnoea, elevated body temperature, and rhinorrhoea. Several endocrinological disorders were known in the patient’s family. Echocardiography ...

Crinetics Pharmaceuticals, Inc. is developing an oral nonpeptide drug for acromegaly patients. The drug is claimed to have advantages over injectable and oral somatostatin analogues. A phase 3 trial ...